Ariad shares plunge as study halt stokes fear of drug's future Reuters India The drug, Iclusig, was granted accelerated approval by the U.S. Food and Drug Administration in December to treat two rare forms of blood cancer, but only with labels warning of the potential for blood clots and liver toxicity. "People are afraid that ... |
